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Gilles de la Tourette syndrome (GTS) is characterized by multiple motor and phonic tics and high comorbidity
rates with other neurobehavioral disorders. It is hypothesized that frontal-subcortical pathways and a complex
genetic background are involved in the etiopathogenesis of the disorder. The genetic basis of GTS remains elusive.
However, several genomic regions have been implicated. Among them, 17q25 appears to be of special interest, as
suggested by various independent investigators. In the present study, we explored the possibility that 17q25 con-
tributes to the genetic component of GTS. The initial scan of chromosome 17 performed on two large pedigrees
provided a nonparametric LOD score of 2.41 near D17S928. Fine mapping with 17 additional microsatellitemarkers
increased the peak to 2.61 ( ). The original families, as well as two additional pedigrees, were genotypedPp .002
for 25 single-nucleotide polymorphisms (SNPs), with a focus on three genes in the indicated region that could play
a role in the development of GTS, on the basis of their function and expression proﬁle. Multiple three-marker
haplotypes spanning all three genes studied provided highly signiﬁcant association results ( ). An independentP ! .001
sample of 96 small families with one or two children affected with GTS was also studied. Of the 25 SNPs, 3 were
associated with GTS at a statistically signiﬁcant level. The transmission/disequilibrium test for a three-site haplotype
moving window again provided multiple positive results. The background linkage disequilibrium (LD) of the region
was studied in eight populations of European origin. A complicated pattern was revealed, with the pairwise tests
producing unexpectedly high LD values at the telomeric TBCD gene. In conclusion, our ﬁndings warrant the further
investigation of 17q25 as a candidate susceptibility region for GTS.
Introduction
Gilles de la Tourette syndrome (GTS [MIM %137580])
is a neurodevelopmental disorder with onset in child-
hood. The phenotype includes the presence of multiple
motor and phonic tics that occur in bouts and that wax
and wane in severity over a period of days, weeks, or
months (Leckman 2002). Tics are sudden habitualmove-
ments or vocalizations that typically mimic some frag-
ment of normal behavior and involve discrete muscle
groups (Leckman and Riddle 2000). The mean age at
onset of the disorder is 7 years (range 2–15 years), and,
in uncomplicated cases, the severity of tics peaks early
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in the 2nd decade of life, with symptoms often showing
a striking decline in frequency and severity by age 19
years (Leckman et al. 1998). This suggests that the sub-
strate for GTS is not neurodegeneration; rather, the dis-
order may be due to features of the developing brain
that are present to a lesser degree in the mature nervous
system.
Once thought to be as rare as 1–10/10,000, GTS is
now considered much more common, with estimated
prevalence in the range of 1%–3.8% (Singer 2000; Rob-
ertson 2003). This variation among studies can prob-
ably be attributed to selection of the target population
and ascertainment bias. Tics have the greatest effect on
a patient’s self-esteem and peer and family relationships
during ages 7–12 years. The high comorbidity of GTS
with other behavioral disorders detracts evenmore from
the patient’s quality of life (Spencer et al. 1998; Carter
et al. 2000; Elstner et al. 2001; Peterson et al. 2001).
Indeed, the behavioral spectrum of GTS and related tic
disorders includes obsessive-compulsive (OC) symptoms
or even formal obsessive-compulsive disorder (OCD
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Table 2
STRPs Used for Linkage Analysis in Large Families
MARKER
PHYSICAL
POSITIONa
(bp)
GENETIC POSITIONb (IN CM),
ACCORDING TO
DeCode Ge´ne´thon Marshﬁeld
D17S849c 386,285 .63 .6 .63
D17S938c 6,194,052 17.06 14.8 14.69
D17S945c 9,766,279 27.99 22 21.01
D17S799c 13,114,012 37 32.8 31.96
D17S925c 27,158,736 52.17 49.5 49.67
D17S798c 31,138,469 55.6 53.9 53.41
D17S933 33,045,783 62.09 58.3 57.71
D17S1814 38,029,065 68.61 62.2 61.48
D17S1299 38,903,071 NA NA 62.01
D17S791c 45,098,507 NA 65 64.16
D17S1795 48,267,058 75.53 69.4 68.44
D17S787c 53,523,963 NA 75.7 74.99
D17S1799 53,782,650 81.61 75.7 74.99
D17S957 55,815,576 87.36 81.7 80.38
D17S808c 61,012,911 91.86 84.2 82.56
D17S1816 64,838,112 95.49 87.6 85.94
D17S949c 68,929,847 102.96 94.9 93.27
D17S1826 70,999,722 106.23 97.2 95.99
D17S1352 72,462,356 110.6 99.3 98.14
D17S1807 72,824,696 113.1 100.4 99.21
D17S785 74,895,412 115.34 104.7 103.53
D17S802c 76,695,601 120.84 108.2 106.8
D17S1847 77,485,779 123.75 112.3 111.22
D17S836 77,760,910 125.04 114 112.92
D17S1806 77,906,603 NA 115.4 114.41
D17S1822 78,344,934 129.24 117.7 116.86
D17S1830 78,360,040 NA 117.7 116.86
D17S784c 78,366,192 129.62 117.7 116.86
D17S928c 80,782,601 135.67 128.7 126.46
17qter STR 81,447,000 NA NA NA
a Physical position refers to the beginning of each STRP. Posi-
tions are based on National Center for Biotechnology Information
build 33. Both physical and genetic positions for the STRPs used
can be found at the University of California–Santa Cruz Genome
Bioinformatics Web site, except for 17qter STR (the position of
which is based on local contig assembly).
b Genetic positions are given relative to pter. NA p not
applicable.
c ABI PRISM linkage mapping set.
[MIM %164230]), other anxiety disorders, mood dis-
orders, and attention-deﬁcit and disruptive behavior
disorders (Kurlan et al. 2002). It seems likely that these
disorders share a common or overlapping neurobiologi-
cal basis.
The neuroanatomic localization of GTS is unknown,
but it is currently thought that the pathophysiology
of the disorder involves the cortico-striatal-thalamo-
cortical circuits (Singer and Minzer 2003). A popular
model of basal ganglia functional anatomy suggests that
involuntary movements are associated with decreased
inhibitory output from the basal ganglia resulting in
excessive activity in fronto-cortical areas (Mink 2001).
This model has been invoked to explain several “hy-
perkinetic” movement disorders (tics, chorea, and dys-
tonia), as well as many psychiatric disorders (schizo-
phrenia, OCD, and depression). It has been hypothesized
that the same mechanisms that are involved in habit
formation are also involved in tics (Leckman and Riddle
2000).
Several lines of evidence suggest that GTS is an in-
herited disorder. In twin studies, the concordance rate
was 53%–56% in MZ twins versus 8% in DZ twins,
indicating a genetic basis of the disorder (Price et al.
1985; Hyde et al. 1992). At the same time, the fact that
the concordance rate between MZ twins is not 100%
demonstrates the importance of environmental or other
nongenetic factors in the pathogenesis of the disorder.
First-degree relatives of individuals with GTS have a
10- to 100-fold increased risk of developing the disor-
der, compared with individuals in the general popula-
tion (Pauls et al. 1991). Early segregation-analysis stud-
ies reported either a pattern consistent with autosomal
dominant inheritance (Pauls and Leckman 1986; Eapen
et al. 1993) or a model in which the penetrance of
heterozygous individuals was intermediate between
those of the homozygotes (Hasstedt et al. 1995). More
recent studies, however, were interpreted as showing
evidence for a signiﬁcant multifactorial (polygenic)
background (Walkup et al. 1996). On the other hand,
Seuchter et al. (2000) could not support Mendelian
transmission of GTS and related conditions. Neverthe-
less, the majority of studies suggest that the etiology of
GTS has a strong and, most likely, complex genetic
component.
Despite the numerous genetic studies undertaken by
various groups (reviewed by Pauls [2003] and Singer
[2000]) targeting a large number of both large pedigrees
and small nuclear families, the genetic basis of GTS has
so far remained elusive, accentuating the likelihood of
the heterogeneity of the disorder. To date, neuroleptics
are the main treatment for GTS, suggesting that a dys-
function in dopaminergic pathways might be implicated
in the development of the disorder. Consequently, sev-
eral genes involved in these pathways have been studied,
but their role in the etiopathogenesis of GTS still re-
mains unclear. A positive-association result between the
dopamine receptor gene DRD4 (MIM 126452) and
GTS has been reported (Grice et al. 1996; Cruz et al.
1997; Dı´az-Anzaldu´a et al. 2004), but other studies
have failed to replicate this result (Brett et al. 1995;
Hebebrand et al. 1997; Comings et al. 1999). Positive
association was also found between the monoamine oxi-
dase A gene (MAOA [MIM 309850]) and GTS (Gade et
al. 1998; Dı´az-Anzaldu´a et al. 2004). Chromosomal ab-
normalities in individuals and families with GTS have
also been studied in the hope of identifying a gene or
genes of major effect that would be disrupted by the
rearrangement (Brett et al. 1996; Kroisel et al. 2001;
Petek et al. 2001; Crawford et al. 2003; and State et
548 Am. J. Hum. Genet. 75:545–560, 2004
Figure 1 Multipoint linkage analysis (GENEHUNTER) of large pedigrees (Yale sample). A, Analysis of TSO and TSC with initial STRP
panel. B, Analysis by use of a ﬁne-mapping STRP panel.
al. 2003, among others). Using this approach, Verkerk
et al. (2003) hypothesized that disruption of the con-
tactin-associated protein 2 gene (CNTNAP2 [MIM
604569]) could lead to the GTS phenotype. Simonic et
al. (1998), in a genomewide search using a case-control
strategy, reported positive associations, with markers in
seven regions and, in a subsequent study, provided ad-
ditional evidence for loci on chromosomes 2, 8, and 11
(Simonic et al. 2001). It is interesting that linkage was
found with the same marker on chromosome 11 re-
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Table 3
Nonparametric Single-Point Linkage
Analysis (GENEHUNTER)
Pedigree and Marker NPL Score P
TSO:
D17S784 1.97 .007
D17S928 1.54 .017
TSC:
D17S802 1.70 .041
D17S928 1.82 .033
TSO and TSC:
D17S802 1.67 .026
D17S784 2.19 .007
D17S928 2.39 .004
ported by Simonic et al. in a large French Canadian
pedigree that was analyzed by use of a multipoint ap-
proach (Me´rette et al. 2000).
Whole-genome scans performed either on large fami-
lies or on families with two affected sibs have provided
indications for linkage of GTS with several genomic
regions. The results between studies are, however, quite
inconsistent. This is believed to be due to uncertainties
in the deﬁnition of the phenotype, diagnostic assess-
ment, and family ascertainment schemes, as well as a
misspeciﬁed genetic model used for the data analysis.
A partial genome scan in 1991 excluded 50% of the
genome, under the assumption of an autosomal domi-
nant gene in all of the families studied (Pakstis et al.
1991). Barr et al. (1999) reported genomewide signiﬁ-
cant linkage with eight markers, using the affected-pedi-
gree method, a nonparametric approach. In the same
study, two of those markers on chromosomes 5 and 19
also gave weak indications of linkage by use of the
parametric LOD score. A genome screen of 110 affected
sib pairs performed by the Tourette Syndrome Associa-
tion International Consortium for Genetics (TSAICG
[1999]) provided suggestive positive-linkage results with
markers on chromosomes 4 and 8. When affected in-
dividuals in this study were stratiﬁed according to OC
symptoms, signiﬁcant allele sharing was noted for
hoarding phenotypes for markers at 4q34-35, 5q35,
and 17q25.4 (Zhang et al. 2002).
Among the regions providing indications for linkage
to GTS so far, we considered 17q25 to be of particular
interest, as suggested by various independent studies
and investigators. A genomewide linkage study per-
formed on a large pedigree from Utah gave the highest
LOD score (2.2) at marker D17S802 (106 cM from
17pter) (Leppert et al. 1996). The ﬁnding of evidence
for linkage to marker D17S784 was supported both by
the TSAICG (1999) and by Zhang et al. (2002). The
TSAICG found a weak peak, with a maximum-likeli-
hood score (MLS) of 0.6, at this marker. However, as
mentioned above, Zhang et al. (2002) found a high
nonparametric LOD (NPL) score at marker D17S784
( ) in a subset of affected sib pairs positiveP ! .00002
for the OC symptom of hoarding. These results indi-
cated that 17q25 deserved further evaluation as a pos-
sible GTS-susceptibility locus.
Here, we report results of an initial screen of chro-
mosome 17 and the follow-up ﬁne mapping of the can-
didate region. Furthermore, the linkage disequilibrium
(LD) pattern of the region was studied in samples from
eight populations of European ancestry to facilitate the
interpretation of our association results and to provide
background information for subsequent studies. Link-
age analysis was performed initially on two large fami-
lies with multiple members affected with GTS. Next, a
map of increased density of STRPs was typed on a total
of four large families, including the two original fami-
lies, as well as two additional pedigrees. For one of the
additional families, additional individuals were added
to extend the pedigree structure. To further reduce the
large candidate interval, we typed 25 SNPs, focusing on
three loci that, according to their expression patterns
and function, could constitute putative susceptibility
genes for GTS—neuronal pentraxin 1 (NPTX1 [MIM
602367]), insulin receptor substrate p53 (IRSP53 [MIM
605475]), and tubulin speciﬁc chaperone D (TBCD
[MIM 604649]). Tests of both single-marker and hap-
lotype association were undertaken, and multiple posi-
tive results were obtained. The same SNPs were then
typed in an independent sample of small nuclear families
participating in the study at a second site (Toronto),
and the initial ﬁndings were replicated to some extent.
Samples and Methods
Samples
The study was approved by the appropriate institu-
tional review boards and ethics committees at both sites
(Yale and Toronto), and informed consent was obtained
from the participating individuals.
Yale family sample.—At Yale, linkage and association
analysis was performed on four large, multigenerational
families with multiple members affected with GTS. The
families investigated originated from Canada, Kansas
(TSK), Michigan (TSM), and Oregon (TSO). The largest
branch of the Canadian family has been analyzed sep-
arately and is designated hereafter as “TSC.” The pedi-
grees are extended to four generations and consist of
462 individuals, with 105 individuals affected with GTS
(68 male and 37 female). None of the married-in spouses
presented with any GTS symptoms, according to our
data. These kindreds have been described in detail else-
where (Kurlan et al. 1986; Pauls et al. 1990; Pakstis et
al. 1991). In all families, each individual was assessed
in a direct interview by use of a structured questionnaire
(Pauls and Hurst 1987). Diagnoses were based on cri-
teria from the revised third edition of theDiagnostic and
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Table 5
TDT for Single Markers (GAS)
SAMPLE AND
MARKER
KNOWN
GENE ALLELE
NO. OF ALLELES
PTransmitted Not Transmitted
Yale families:a
C_11488062_10b … G 27 9 .002
rs3744161c TBCD G 29 17 .052
Canadian families:d
C_11488062_10b … G 18 8 .038
rs662669c TBCD T 23 12 .045
rs3744161c TBCD G 23 11 .029
Toronto families:
C_11600340_10b SECTM1 G 76 49 .0098
rs1056534c TBCD C 65 43 .021
rs662669c TBCD T 65 44 .027
NOTE.—Transmission of all 25 SNPs genotyped was tested. Only statistically signiﬁcant
results are presented here.
a Analysis performed on the entire sample of large families available at the Yale site.
b Applied Biosystems assay SNP ID.
c dbSNP ID.
d Analysis performed on the large Canadian families only.
Statistical Manual (DSM-IIIR) (American Psychiatric
Association 1987) and were reﬁned, as suggested else-
where (Kurlan 1989), to indicate the quality of the in-
formation. This gives subjects a possible, probable, or
deﬁnite diagnosis of GTS or chronic multiple tics. We
decided to take a more conservative approach and con-
sidered as affected in our analysis only those individuals
who presented with deﬁnite or probable GTS, according
to the diagnostic scheme. DNA was extracted, using
standard procedures, from permanent lymphoblastoid
cell lines that were established for all the families at the
Yale site.
Toronto family sample.—In Toronto, 330 individuals
from 96 small, nuclear families were available for analy-
sis. DNA was extracted from whole blood according to
standard procedures. The sample consisted of 41 fami-
lies with one affected child and 55 families with two
affected children. Of the 96 families studied, 90 are of
European origin. Two families of southwestern Asian
origin and one family of East Asian origin were also
included in the sample. In addition, in two families, the
father is of European origin, and the mother is East
Asian; in one family, the mother is European and the
father is African American. The diagnostic assessment
of these families has been described elsewhere (TSAICG
1999). In brief, information about symptoms associated
with GTS was collected, using a self- and family report,
on the basis of the Yale Global Tic Severity Scale (Leck-
man et al. 1989). The information was checked by an
experienced neuropsychiatrist or neurologist, who also
performed a direct examination of each proband.
Yale population samples.—Background LD in the ge-
nomic region studied was estimated in unrelated samples
from seven populations originating from Europe (Ady-
gei, Chuvash, Russians, Ashkenazi Jews, Finns, Danes,
and Irish). A more diverse sample of European Ameri-
cans was also studied. The mean sample size was 65
individuals. The vast majority of families used for link-
age and association studies here (all of the Yale families
and 90 of 96 Toronto families) are of European descent,
and their ethnic origin cannot be easily deﬁned any fur-
ther. The populations used to obtain background infor-
mation are representative of European ancestry, espe-
cially given the fact that genomic variation among
European populations is quite homogeneous (Kidd et
al., in press). Descriptive information and literature ci-
tations for these population samples can be found in the
Allele Frequency Database (ALFRED) under the unique
identiﬁcation numbers (UIDs) shown in table 1. DNA
was extracted from lymphoblastoid cell lines available
at the Yale site.
Genotyping
STRPs.—For the initial screen, the TSO and the TSC
pedigrees were typed for 13 markers on chromosome
17 (ABI PRISM linkage mapping set, panels 24 and 25).
The average intermarker distance was 10 cM. All of the
large pedigrees at the Yale site were then typed for 17
additional STRPs, increasing the density of the map be-
tween marker D17S798 and 17qter (table 2). All STRPs
were typed by use of ﬂuorescently labeled primers for
PCR ampliﬁcation, and electrophoresis of the denatured
products was performed on an acrylamide gel by use of
the ABI 377 instrument. The ﬁne-mapping markers were
organized into two sets, so as not to overlap, according
to their ﬂuorescent label, and allele size and the PCR
products of each set were pooled before electrophoresis.
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Table 6
Results of TDT by Use of 3-Site–Haplotype Sliding Window in the Yale Families
SNPSa AND
HAPLOTYPE
TRANSMISSIONS
VAR(OBSERVED
EXPECTED) (P)2x
GLOBAL 2x
(P)bObserved Expected
2-3-4:
A-G-G 34.805 41.065 8.16 4.79 (.021c) 6.68d (.271c)
3-4-5:
G-A-G 34.275 28.078 5.76 6.65 (!.001)
NCG-A-A 16.313 21.648 3.73 7.62 (.01)
4-5-6:
G-A-G 12.771 9 1.93 7.31 (!.001)
18.07e (.022)G-G-A 21.98 27.37 8.78 3.31 (.031)
5-6-7:
G-G-C 38.10 31.88 8.22 4.7 (.041)
17.08e (.019)A-G-T 4.44 3.18 .89 1.79 (.02)
6-7-8:
A-C-G 44.05 52.8 9.75 7.86 (.001)
16.03e (.01)G-C-T 43.33 35.96 10 5.40 (.005)
7-8-9:
C-G-A 49.83 55.85 10.281 3.519 (.043) 8.08e (.122)
8-9-10:
T-A-G 8.53 5.58 2 4.28 (!.001)
36.4f (.041c)T-G-G 11.014 16.18 2.79 9.54 (.001)
9-10-11:
G-G-C 17.26 25.75 7.07 10.186 (!.001) 33.109g (.001)
11-12-13:
C-A-A 63.915 59.26 5 4.31 (.032)
13.5f (.081)T-A-A 7.71 5.63 1.65 2.62 (.002)
12-13-14:
A-A-C 71.414 65.465 5.24 6.74 (.016) 37.3f (.023)
13-14-15:
G-C-A 29.92 40.624 14 8.14 (.019) 8.62d (.341c)
17-18-19:
T-T-G 14.811 21.017 6.36 6.05 (!.001)
20.82e (.007)C-T-G 9.13 14 3.37 7.04 (.029)
18-19-20:
T-G-G 15.693 24.356 6.66 11.268 (!.001)
21.72g (.009)T-T-A 12.823 9.91 2.79 3.025 (.002)
19-20-21:
T-A-G 13.83 10.464 2.66 4.25 (!.001) NC
20-21-22:
A-G-G 16.792 12.966 3.1 4.72 (!.001) NC
21-22-23:
G-G-T 24.2 19.047 4.52 5.86 (!.001c) NC
23-24-25:
C-T-C 4.86 3.68 1.16 1.20 (.005) 12.669e (.165)
NOTE.—Results shown for joint analysis of all pedigrees.
a SNP numbers correspond to SNP order shown in table 1.
b NC p value could not be calculated.
c Used c5 ﬂag.
d 4 df.
e 7 df.
f 5 df.
g 6 df.
The primers used for PCR ampliﬁcation can be found
at the GenLink site for all markers, except for the 17qter
STR. This is an STRP identiﬁed in our lab; the primers
and the ampliﬁcation conditions can be found on the
ALFRED Web site. Size assignment and allele calling
were performed using GeneScan and Genotyper software.
SNPs.—Twenty-ﬁve SNPs were typed in all families
available for this study. The SNPs were chosen from the
Applied Biosystems “assays on demand” catalogue and
were typed as 5′ TaqMan assays (Livak 1999). Most of
the SNPs are intronic, with no apparent functional sig-
niﬁcance. SNPs rs3214032 and rs1056534 are exonic
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Table 7
Results of TDT by Use of 3-Site–Haplotype Sliding Window in the Toronto Families
SNPSa AND
HAPLOTYPE
TRANSMISSIONS
VAR(OBSERVED
EXPECTED) 2x P GLOBAL (P)2xObserved Expected
2-3-4:
G-G-G 2.37 5.95 2.16 5.91 .017b 17.294c (.027b)
3-4-5:
G-A-G 25.80 20.14 6.45 4.97 !.001 9.54c (.076)
4-5-6:
G-G-G 13.04 17.27 5.58 3.19 .02 6.25c (.308)
7-8-9:
C-T-A 14.90 11.44 3.10 3.85 .032 6.56c (.447)
11-12-13:
T-C-G .68 4.03 1.52 7.36 !.001 8.26d (.035)
12-13-14:
C-G-C .88 5.17 2.06 8.93 !.001
11.173e (.007)C-A-T 1.06 2.28 .96 1.53 !.001
14-15-16:
C-G-C 95.10 81.59 26.52 6.88 .017 10.762c (.064)
15-16-17:
G-C-T 101.10 85.40 27.16 8.97 .004f 10.557d,f (.037f)
18-19-20:
C-G-A 35.04 44.71 14.82 6.31 .002 7.98d (.012)
a SNP numbers correspond to SNP order shown in table 1.
b Used agg3 ﬂag.
c 7 df.
d 4 df.
e 5 df.
f Used c5 ﬂag.
but code synonymous changes. The total region screened
spans 4.8 Mb, with greater marker density in three
regions of 135 kb (NPTX1 locus), 80 kb (IRSP53 locus),
and 199 kb (TBCD locus) (table 1). We studied the
whole of the IRSP53 and TBCD genes, with markers at
an average spacing of ∼10 kb and ∼21 kb, respectively.
In the NPTX1 locus, we studied three SNPs at the 3′
end as well as one SNP in intron 2–3 of the gene. The
SNPs were chosen on the basis of their heterozygosity
and also their chromosomal position. An attempt was
made to investigate in more detail the region that pro-
duced high NPL scores but had low STRP coverage. At
the same time, the genes studied could constitute can-
didate genes for GTS. In this article, for reasons of sim-
plicity, we refer to each of the SNPs by its order number,
as shown in table 1.
Statistical Analysis
The STRP genotyping data were used to perform both
single- and multipoint nonparametric linkage analysis,
as implemented by GENEHUNTER (Kruglyak et al.
1996). STRP allele frequencies were calculated in the
unrelated individuals in the sample by use of locally
written software. Haplotypes shared identical by descent
among affected individuals were examined in detail in
the families yielding high NPL scores (TSC and TSO).
Haplotypes were constructed using GENEHUNTER
and were then compared among affected and unaffected
individuals in each pedigree.
The transmission/disequilibrium test (TDT) for indi-
vidual markers (Spielman et al. 1993) was performed
using the software package GAS. The program TRANS-
MIT (Clayton 1999) was used for the inference of hap-
lotypes in the family samples and for the implementation
of a haplotype-based TDT. The bootstrap option of the
program was used, and, for each haplotype, the test was
replicated 1,000 times, thus deriving exact P values. For
some of the intervals, in which rare haplotypes or alleles
existed, the c5 or agg3 ﬂags were used to disregard
rare haplotypes (frequency !0.05) or aggregate rare al-
leles (frequency !0.03), respectively, before haplotype
construction.
Allele frequencies of individual SNP sites were cal-
culated by gene counting. The assumption of Hardy-
Weinberg ratios was tested by means of an auxiliary
program, FENGEN (Kidd et al. 1998). The multisite
haplotype frequencies were calculated with HAPLO
(Hawley and Kidd 1995), which implements the expec-
tation-maximization algorithm. By use of the haplotype
frequency estimates, pairwise LD coefﬁcients were com-
puted as (Pritchard and Przeworski 2001). The2D
HAPLO/P program (Zhao et al. 1999) was used to per-
form permutation-based calculations of the pairwise LD
values and to provide a test of statistical signiﬁcance.
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Figure 2 Pairwise LD tests at IRSP53 and TBCD regions (X-axis corresponds to distance in kb; LD values are shown at the midpoint
of each interval). A, Tests at IRSP53 are signiﬁcant for all the populations at for the intervals between SNPs 11 and 12, 12 and 13,P ! .006
and 13 and 14. At the interval between SNPs 8 and 9, the test is signiﬁcant at for Chuvash, Russians, Danes, Irish, and EuropeanP ! .002
Americans. B, Analysis of the TBCD region. Each point corresponds to adjacent SNP intervals (SNPs 16–17, 17–18, 18–19, 19–20, 20–21,
21–22, 22–23, 23–24, and 24–25). All values are associated with , except for the test for the ﬁnal interval (SNPs 24–25) for the2D P ! .001
Chuvash ( ).Pp .014
Results
Linkage and Association Studies
The results of the initial scan of chromosome 17, by
use of only the ABI panel STRPs and a multipoint link-
age analysis approach on each pedigree, are shown in
ﬁgure 1A. Analysis of the TSO genotyping data gave a
peak between marker D17S784 and 17qter (Z pall
) and a smaller peak at marker D17S798 (2.19 Z pall
). For TSC, three peaks were detected, at markers1.03
D17S791 ), D17S802 ), and(Z p 1.31 (Z p 1.67all all
D17S928 ( ). With both pedigrees analyzedZ p 1.51all
together, the multipoint NPL score reached 1.61 at
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marker D17S791, whereas, at 17q25, a broad peak be-
tween markers D17S802 and D17S928 was produced
(highest at marker D17S928; ).Z p 2.46 Pp .0037all
Results of the single-point analysis are shown in table
3. For TSO, the highest NPL score was produced at
marker D17S784 with an associated P value of .007,
whereas TSC gave the highest NPL score at marker
D17S928 ( ). Single-point nonparametric link-Pp .033
age analysis of the genotyping data of both pedigrees
produced interesting NPL scores at markers D17S784
( ) and D17S928 ( ).Pp .007 Pp .004
We decided to pursue these ﬁndings further and to in-
crease the density of markers between marker D17S798
and 17qter. To this end, we typed 17 additional STRPs
in both of these pedigrees as well as in additional indi-
viduals from TSC, TSK, and TSM. For TSO, the peak
sharpened and shifted to marker D17S928, reaching a P
value of .003, whereas the peak at marker D17S798 was
reduced (ﬁg. 1B). For TSC, the peak at marker D17S791
became more distinct, whereas, at 17q25, there was a
broad peak between markers D17S802 and D17S1822
and a sharper peak at marker D17S928 (ﬁg. 1B). With
both pedigrees analyzed together, the peak NPL score at
marker D17S928 reached 2.61, with a P value of .002.
Multipoint analysis of the TSK pedigree produced an
NPL score that peaked close to marker D17S802
( ; ), whereas TSM analyzed aloneZ p 1.35 Pp .07all
did not provide positive results in this region (data
not shown). When all of the families were analyzed to-
gether, the NPL score only reached 1 ( ) close toPp .09
marker D17S928 (ﬁg. 1B).
We examined in detail the haplotypes that were shared
identical by descent in the two pedigrees (TSC and TSO)
and that yielded the highest NPL scores. The pattern of
haplotypes inherited by the affected individuals is quite
complex, with no single haplotype always segregating
with the affection status in either of the families ana-
lyzed. However, excessive haplotype sharing among af-
fected individuals could be seen (table 4). In TSO, two
haplotypes account for 43.3% of the chromosomes in
the affected individuals and only 5.7% of the chromo-
somes in the unaffected individuals. In TSC, two differ-
ent haplotypes in the same region are inherited identical
by descent in 32.35% of the chromosomes in individuals
with GTS and are found in only 8% of the chromosomes
of the unaffected individuals.
We continued our ﬁne-mapping efforts, focusing
on 17q25 and, particularly, the regions producing the
highest NPL scores. We typed 3 SNPs around marker
D17S802 and 22 SNPs between markers D17S784 and
17qter STR. Initially following a map-based approach,
we chose to type SNPs in regions that gave strong in-
dications of linkage but had low STRP coverage in our
analysis. At the same time, 22 of the SNPs studied span
three genes (NPTX1, IRSP53, and TBCD) that, ac-
cording to their expression patterns and functions, could
constitute susceptibility candidates for GTS (see the
“Discussion” section). Finally, we decided to study
TBCD, the last known gene on chromosome 17, as an
anchoring point for our analysis.
The TDT revealed overtransmission of alleles and
positive association with one SNP close to marker
D17S802 (C_11488062_10) and two in the TBCD re-
gion (rs662669 and rs3744161) (table 5). To make the
sample more informative, we continued our analysis,
performing an association test with a three-site–haplo-
type moving window. Two-site–haplotype tests were also
performed, but they did not add any information and
pointed toward the same regions (data not shown).Mul-
tiple small haplotypes, spanning most of the region stud-
ied, were found to be overtransmitted or undertrans-
mitted to affected offspring (table 6).
This intriguing result required replication in an in-
dependent sample. Our collaborators at the Toronto
Western Hospital agreed to type their sample of small
nuclear families with one or two members affected with
GTS for the 25 SNPs that we had typed in the large
pedigrees. The TDT revealed positive association, with
three of the markers (C_11600340_10, rs1056534,
and rs662669) having an allele overtransmitted to the
affected offspring (table 5). Markers rs1056534 and
rs662669 are situated at the beginning of the TBCD
gene, whereas marker C_11600340_10 resides 400 kb
upstream of TBCD at an intronic region of secreted and
transmembrane protein 1 (SECTM1 [MIM 602602]).
The same allele of rs662669 that was overtransmitted
in the Yale sample was also transmitted in excess in the
Toronto sample. The three-site–haplotype TDT pro-
duced positive ﬁndings in six small haplotype regions
(table 7).
LD Patterns
We collected background information about the SNPs
included in this study, to allow better interpretation of
our association results and to provide a framework for
subsequent studies. Since all the families analyzed at Yale
and most of the families analyzed in Toronto are of
European descent, we calculated the SNP frequencies
and the pairwise LD values in unrelated samples from
eight populations of European origin. The pairwise LD
tests were performed between SNPs at the three loci
(NPTX1, IRSP53, and TBCD) that were studied at a
somewhat higher density.
The frequencies of all SNPs that were genotyped are
shown in table 1. The table shows only the results of
pairwise LD tests between consecutive SNPs. AtNPTX1,
we studied four SNPs spanning 135 kb at an aver-
age spacing of 45 kb. Moderately signiﬁcant LD was
found only between SNPs 4 and 5 (C_152603_10 and
C_465993_10), with an associated P value of !.006 for
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all the populations studied. At IRSP53, seven SNPs were
studied spanning 80 kb at average intervals of 13 kb
(ﬁg. 2A). The highest LD was observed between SNPs
8 and 9 (C_216379_10–C_150018_10), SNPs 11 and
12 (C_213917_10–C_179850_10), and SNPs 12 and
13 (C_179850_10–C_209341_10). The LD test results
are most interesting at the telomeric TBCD region (ﬁg.
2B). One would expect little or no LD between markers,
because of generally high recombination rates near telo-
meres. However, in a region spanning 199 kb with 10
SNPs at an average spacing of 22 kb, there is high LD
between all the marker pairs studied. If selection has not
operated, this ﬁnding indicates low recombination rates
across this telomeric region. It should also be noted that,
in all three regions, LD does not break down with dis-
tance in a simple manner (data not shown). The popu-
lations studied are historically close and genetically ho-
mogeneous, when compared with other regions of the
world (Tishkoff et al. 1998; Kidd et al. 2000, in press).
In the regions analyzed here, some variation among popu-
lations is seen, but it does not appear signiﬁcant.
Discussion
We have presented several lines of evidence implicating
17q25 in the etiopathogenesis of GTS. Our study was
initiated as a ﬁne-mapping effort following up on pre-
vious indicative ﬁndings. Nonparametric linkage analy-
sis in the multigenerational pedigrees included in this
study provided indications of linkage with a region be-
tween markers D17S802 and D17S784 as well as be-
tween marker D17S928 and 17qter STR. A previous
linkage analysis study, performed on a large pedigree
from Utah, yielded a parametric LOD score of 2.2 at
marker D17S802 (Leppert et al. 1996). On the other
hand, marker D17S784 produced one of the highest
NPL scores in the genome screen performed by Zhang
et al. (2002) on families with two sib pairs affected with
GTS who were concordant for the OC phenotype of
hoarding. In view of these previous results, our ﬁndings
on independent samples become more signiﬁcant.
In addition to the positive linkage suggested in the
large pedigrees studied, we obtained multiple positive
association results after analyzing the genotyping data
from the 25 SNPs that we typed in our region of interest.
TDT results with single markers point in the direction
of the TBCD gene as well as to the region close to
marker D17S802. A TDT that we performed using a
three-site–haplotype sliding window seems also to be
implicating the other two genes investigated (NPTX1
and IRSP53).
An independent sample of 96 small nuclear families
with one or two children affected with GTS and their
parents, was genotyped for the SNPs included in our
initial study. The results make our case stronger by rep-
licating a ﬁnding of positive association with two mark-
ers in the TBCD region as well as with over- or under-
transmitted haplotypes in the entire region studied. The
fact that the large-family sample produces many more
positive results with the haplotype approach than do
the Toronto small families can be explained by the na-
ture of the sample. It is expected that fewer genetically
independent haplotypes will exist in a sample of large
families, thus reinforcing the positive results. It has also
not escaped our attention that in each of the two family
samples studied, different haplotypes are associated
with GTS. This may be due to the LD pattern of the
region. In genomic regions of low LD, the recombina-
tion rates are simply too high, increasing the number
of observed haplotypes. Thus, mutations involved in the
etiology of GTS may have occurred on multiple hap-
lotype backgrounds. On the other hand, for intervals
demonstrating strong LD (as is the case, e.g., in the
TBCD region studied here), the existence of multiple
haplotypes that are positively associated with the dis-
order implies the presence of more than one mutation
allele. We have to note that, at this point, this is only
speculation.
The two families that were used for the initial scan
of chromosome 17 (TSO and TSC) have also been used
in a whole-genome scan that did not produce any posi-
tive ﬁndings in the region investigated here (Barr et al.
1999). In that study, the diagnostic scheme used was
much broader, including subjects who presented with
chronic motor tics in the analysis of affected individuals.
Furthermore, different statistics were estimated (the
parametric LOD score and the nonparametric affected-
pedigree method statistic).
We believe that, in the current study, the fact that not
all large families show linkage to the markers suggested
in the two largest pedigrees simply underlines the het-
erogeneity of the disorder. Bilineality of susceptibility
transmission in large families is an issue that has long
been proposed as the cause that hampers the linkage
analysis studies on large pedigrees with GTS (Comings
et al. 1989; Kurlan et al. 1994).
The comorbidity of GTS with other psychiatric dis-
orders could be explained by a common neurological
basis. OC symptoms among individual with GTS range
from 11%–80% (King et al. 1998), whereas 30% of
adults with GTS meet full criteria for OCD. Hanna et
al. (2002), in a recent genomewide scan for OCD, ob-
tained a suggestive NPL score of almost 1 at a marker
close to 17qter. Mood disorders have also been asso-
ciated with GTS, and some studies have suggested that
bipolar disorder is overrepresented in patients with GTS
(Kerbeshian et al. 1995; Berthier et al. 1998; Robertson
2000). A recent genomewide linkage analysis of bipo-
lar disorder produced a LOD score of 2.4 at marker
D17S928 (Dick et al. 2003). Such overlapping ﬁndings
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could be of special interest for disentangling the asso-
ciation of different psychiatric-disease phenotypes.
The genes studied in greater detail here could con-
stitute candidate susceptibility genes for GTS. All three
are related to neuronal plasticity, maintenance, and de-
velopment. NPTX1 is a gene with a protein product
that is expressed almost exclusively in the human brain
and plays a role in excitatory synaptogenesis, most
likely in the developing brain (Omeis et al. 1996; Xu
et al. 2003). Insulin receptor substrate protein p53
(IRSP53) is also expressed primarily in the brain and
functions as an insulin receptor tyrosine kinase substrate
(Abbott et al. 1999). It is considered to play an impor-
tant role in neurite outgrowth, inﬂuencing the shape
and dynamic of cytoskeletal structures (Oda et al. 1999;
Krugmann et al. 2001; Bockmann et al. 2002). It has
also been identiﬁed as interacting with the dentatoru-
bral-pallidoluysian atrophy (DRPLA) gene, which is as-
sociated with a neurodegenerative disease (Okamura-
Oho et al. 1999). DRPLA symptoms are similar to those
of Huntington disease and include chorea, ataxia, lack
of coordination, and dementia (Ross et al. 1997). The
third gene we chose to study encodes TBCD, a protein
important for the correct folding of tubulin and the
formation of the functional ab-heterodimer (Fleming et
al. 2000). When overexpressed in vitro, it acts as a
microtubule-destabilizing protein (Martin et al. 2000).
As part of the microtubule-assembly machinery, TBCD
may play an important role in the establishment of neu-
ral networks as well as axonal transport and mainte-
nance. It has been recently shown that mutations in the
proteins responsible for the folding and assembly of
tubulin subunits into functional heterodimers can cause
neurological disease (Bommel et al. 2002; HRD/Auto-
somal Recessive Kenny-Caffey Syndrome Consortium
2002; Martin et al. 2002).
The etiopathogenesis of GTS seems to result from the
interaction of genetic susceptibility, environmental fac-
tors, and neurobiological systems active in the devel-
oping brain. It is clear that the disorder is both genet-
ically and phenotypically heterogeneous. Our study has
identiﬁed three genes that could confer susceptibility or
protection for GTS and that should be further investi-
gated. The identiﬁcation of genes that contribute to the
genetic component of GTS will lead treatment of the
disorder in new directions and will elucidate the com-
plex brain procedures involved in habit formation and
tics.
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